Amedisys, Inc. provided earnings guidance for the year 2022. For the year, the company expects revenue of $2.224 billion to $2.23 billion and EPS of $4.82 to $4.93.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
91.77 USD | +0.19% |
|
-0.05% | -3.46% |
24/04 | Earnings Flash (AMED) AMEDISYS Reports Q1 EPS $1.03 | MT |
24/04 | Amedisys, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.46% | 299.88Cr | |
+27.57% | 191.53Cr | |
0.00% | 181.94Cr | |
+61.78% | 68Cr | |
-17.49% | 43Cr | |
-44.72% | 31Cr | |
-27.91% | 15Cr | |
-13.44% | 13Cr | |
+3.85% | 6.92Cr |
- Stock Market
- Equities
- AMED Stock
- News Amedisys, Inc.
- Amedisys, Inc. Provides Earnings Guidance for the Year 2022